Medicare Part D Coverage Gap Discount Proposal Challenged In Study

13 Sep 2016
Analysis

Cathy Kelly Catherine.Kelly@informa.com

Executive Summary

Analysis sponsored by a biopharma-backed group challenges MedPAC proposal for changing Part D procedures in a way that could reduce beneficiary incentives to choose high-cost branded drugs while in the coverage gap.

Already Registered? Sign in to continue reading.

New to Pink Sheet? Start a free trial today!

Table
View full table

Topics

United States

Related Companies

ASK THE ANALYST
Email

Print
Bookmark
Share

Tags:

Reimbursement Market Access Medicare

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

PS119120

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

PS119120

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.

Medicare Part D Coverage Gap Discount Proposal Challenged In Study

Analysis

Executive Summary

Related Content

Part D Reform Proposals From MedPAC May Find Traction After Election

Topics

Related Companies

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Register

Ask The Analyst

Email Article

Sign In To Set a Search Alert